Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.

Horne, David J; Kohli, Mikashmi; Zifodya, Jerry S; Schiller, Ian; Dendukuri, Nandini; Tollefson, Deanna; Schumacher, Samuel G; Ochodo, Eleanor A; Pai, Madhukar; Steingart, Karen R

Horne, David J; Kohli, Mikashmi; Zifodya, Jerry S; Schiller, Ian; Dendukuri, Nandini; Tollefson, Deanna; Schumacher, Samuel G; Ochodo, Eleanor A; Pai, Madhukar; Steingart, Karen R.

Afiliación

Horne DJ; Department of Medicine, Division of Pulmonary and Critical Care Medicine, and Firland Northwest TB Center, University of Washington, Seattle, WA, USA.

Cochrane Database Syst Rev ; 6: CD009593, 2019 06 07.

Article en En | MEDLINE | ID: mdl-31173647

Asunto(s)

Antibióticos Antituberculosos; Farmacorresistencia Bacteriana; Mycobacterium tuberculosis; Rifampin; Tuberculosis Pulmonar; Antibióticos Antituberculosos/farmacología; Humanos; Pruebas de Sensibilidad Microbiana; Mycobacterium tuberculosis/efectos de los fármacos; Rifampin/farmacología; Sensibilidad y Especificidad; Tuberculosis Pulmonar/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Pulmonar / Farmacorresistencia Bacteriana / Antibióticos Antituberculosos / Mycobacterium tuberculosis Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google